Sign in
4

Changes in Ownership

Raphael Pharmaceutical Inc. Filed Acc 0001213900-25-022736

Chief Executive Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pilo Shlomo Chief Executive Officer 2025-03-02 Grant or award +200,000 $0.50 $100,000 3,983,701 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pilo Shlomo Chief Executive Officer 2025-03-02 Grant or award · Warrant to purchase Common Stock +100,000 1,100,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…